Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Executive Vice President and Chief Financial Officer On October 24, 2026, the Board of Directors of Axcelis Technologies, Inc.…
Filed Oct 27, 2026Accepted Oct 27, 2026, 8:07 AM EDTCIK 1113232Accession 0001104659-26-118986
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of Executive Vice President and Chief Financial Officer
On October 24, 2026, the Board of Directors
of Axcelis Technologies, Inc. (the “Company”) appointed Jeroen Delsman as Executive Vice President and Chief Financial
Officer, effective as of November 12, 2026. Mr. Delsman will succeed David Ryzhik, who has served as the Company’s interim
Chief Financial Officer.
Mr. Delsman, 50, brings 18 years of semiconductor
industry experience and more than 26 years of finance and accounting experience to the Company. Before joining the Company, Mr. Delsman
served as Vice President of Ferrotec USA Corporation, a subsidiary of Tokyo-based Ferrotec Corporation, an advanced materials, components,
systems, and manufacturing solutions company. Before that, he served as Vice President of Finance and Controller of the printed circuit
board division of Sanmina Corporation. He previously served as Vice President of Business Finance and Operations at Veeco Instruments
Inc. (“Veeco”), where he supported the business unit general managers and operations leaders. He has also held various finance
leadership roles at Lam Research Corporation, Novellus Systems, Inc., McKesson Corporation and Silicon Graphics, Inc. Mr. Delsman
began his career in the financial audit division of KPMG in the Netherlands. Mr. Delsman holds a Bachelor of Science in Accounting
from The Hague University of Applied Sciences in the Netherlands and a Master of Business Administration from California Polytechnic State
University, San Luis Obispo.
There are no family relationships between Mr. Delsman
and any director or executive officer of the Company. There are no arrangements or understandings between Mr. Delsman and any other
person pursuant to which he was selected as an officer of the Company, other than his employment arrangements with the Company. There
are no transactions involving Mr. Delsman requiring disclosure under Item 404(a) of Regulation S-K.
Compensatory Arrangements for Chief Financial Officer
In connection with his appointment, on October 26, 2026, the Company
and Mr. Delsman entered into an offer letter agreement (the “CFO Offer”). Pursuant to the CFO Offer:
Mr. Delsman will receive an annual base salary of $500,000.
He will be eligible to participate in the Axcelis Team Incentive plan starting
in 2027, with a target equal to 75% of his base salary.
He will receive a $352,000 sign-on cash bonus, payable upon commencement
of employment. The bonus must be repaid if he voluntarily separates or is terminated for cause within one year following commencement
of employment.
He will receive a sign-on restricted stock unit award with a grant date value
of $1,200,000 (the “Sign-On RSU Award”). The Sign-On RSU Award will vest 33.33% on the six-month anniversary of the grant
date, 33.33% on the second anniversary of the grant date, and 33.34% on the third anniversary of the grant date, subject to continued
employment through each such date.
He will be eligible to receive annual equity awards in connection with the
Company’s annual equity award cycles with an expected grant date target value of at least $1,200,000.
He will receive an $80,000 relocation bonus to support housing, travel, lodging,
and related expenses during the first year of employment. The bonus must be repaid if he voluntarily separates or is terminated for cause
within one year following commencement of employment.
Subject to approval by the board of directors of the combined company following
the closing of the pending merger with Veeco, he is expected to receive a three-year performance-based special equity grant with a grant
date target value of $1,200,000.
Following Mr. Delsman’s commencement of employment with the Company,
he will be subject to the Indemnification Agreement, Change in Control Severance Agreement (with a lump-sum severance multiple under Section 2.2
of such agreement of 1.5) and Executive Separation Pay Agreement, substantially in the forms included as Exhibits 10.2, 10.3, and 10.11,
respectively, to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 26,
2026.
The foregoing summary of the CFO Offer does not purport to be complete
and is qualified in its entirety by reference to the CFO Offer, dated October 26, 2026, which is filed as Exhibit 10.1 to this
Current Report on Form 8-K.
Following Mr. Delsman’s appointment, Mr. Ryzhik will
continue as the Company’s Senior Vice President of Corporate Development and Investor Relations.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On October 27, 2026, the Company issued a press release announcing
Mr. Delsman’s appointment as Executive Vice President and Chief Financial Officer of the Company. A copy of the press release
is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Exhibit 99.1 shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities
under that section and shall not be deemed to be incorporated by reference into any filing of the registrant under the Securities Act
of 1933 or the Exchange Act. A copy of the press release is also available on the Company’s website at https://axcelis.gcs-web.com/news-releases.
Filed exhibits (1)
EX-99.1 (by filename) tm2628310d1_ex99-1.htm
Exhibit 99.1
Axcelis Technologies
Names Jeroen Delsman as Executive Vice President and Chief Financial Officer
BEVERLY, Mass., October 27, 2026
- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor
industry, today announced the appointment of Jeroen Delsman as Executive Vice President and Chief Financial Officer effective November 12,
2026. David Ryzhik, who has served as Interim CFO during the transition period, will assume the new role of Senior Vice President, Corporate
Development and Investor Relations, reporting directly to Russell Low, with responsibility for leading integration planning and execution
related to the pending merger with Veeco, corporate development, investor relations and other strategic initiatives.
President and CEO Russell Low stated,
“We are delighted to welcome Jeroen to Axcelis. He brings deep financial expertise, extensive global industrial and semiconductor
industry experience and, importantly, a strategic mindset and proven leadership abilities to the role. Jeroen has a demonstrated track
record of leading organizations through phases of growth and transformation, building str…